Certara, Inc. (NASDAQ:CERT) Given Consensus Rating of “Moderate Buy” by Analysts

Shares of Certara, Inc. (NASDAQ:CERT) have been given an average recommendation of “Moderate Buy” by the seventeen analysts that are covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell rating, six have issued a hold rating, eight have given a buy rating and two have issued a strong buy rating on the company. The average 12 month price target among brokers that have updated their coverage on the stock in the last year is $12.5833.

Several research firms have issued reports on CERT. Weiss Ratings reiterated a “sell (d+)” rating on shares of Certara in a research report on Monday, December 29th. Craig Hallum began coverage on Certara in a research note on Monday, September 29th. They issued a “buy” rating and a $16.00 price target on the stock. Leerink Partnrs upgraded Certara from a “hold” rating to a “strong-buy” rating in a report on Tuesday, January 6th. Leerink Partners upgraded shares of Certara from a “market perform” rating to an “outperform” rating and set a $13.00 target price on the stock in a report on Tuesday, January 6th. Finally, Barclays cut their target price on shares of Certara from $14.00 to $13.00 and set an “overweight” rating on the stock in a research note on Monday, December 15th.

Certara Price Performance

Certara stock opened at $9.51 on Friday. The stock has a market cap of $1.51 billion, a P/E ratio of 135.86 and a beta of 1.46. Certara has a 12-month low of $8.02 and a 12-month high of $15.69. The company has a current ratio of 2.09, a quick ratio of 2.09 and a debt-to-equity ratio of 0.27. The company has a fifty day simple moving average of $8.95 and a 200-day simple moving average of $10.49.

Certara (NASDAQ:CERT) last announced its quarterly earnings results on Thursday, November 6th. The company reported $0.14 EPS for the quarter, topping the consensus estimate of $0.11 by $0.03. The firm had revenue of $104.62 million for the quarter, compared to analyst estimates of $104.53 million. Certara had a net margin of 2.62% and a return on equity of 5.18%. During the same period last year, the business earned $0.13 EPS. Certara has set its FY 2025 guidance at 0.450-0.470 EPS. Equities analysts expect that Certara will post 0.28 EPS for the current fiscal year.

Institutional Investors Weigh In On Certara

Institutional investors have recently added to or reduced their stakes in the company. AdvisorNet Financial Inc acquired a new position in shares of Certara in the 2nd quarter worth approximately $25,000. First Horizon Corp bought a new position in Certara during the third quarter valued at about $30,000. Versant Capital Management Inc lifted its position in shares of Certara by 66.7% in the third quarter. Versant Capital Management Inc now owns 2,881 shares of the company’s stock worth $35,000 after buying an additional 1,153 shares during the last quarter. Osaic Holdings Inc. boosted its stake in shares of Certara by 50.7% during the 2nd quarter. Osaic Holdings Inc. now owns 3,491 shares of the company’s stock worth $41,000 after acquiring an additional 1,175 shares in the last quarter. Finally, Elevation Point Wealth Partners LLC acquired a new position in shares of Certara during the 2nd quarter valued at about $59,000. 73.96% of the stock is currently owned by institutional investors and hedge funds.

Certara Company Profile

Certara is a biosimulation software and services company that partners with pharmaceutical, biotechnology and medical device developers to accelerate drug discovery, development and regulatory approval. The company’s platform integrates quantitative pharmacology, real-world evidence, artificial intelligence and machine learning to model and simulate drug behavior across a range of therapeutic areas and patient populations. By applying these mechanistic and data-driven approaches, Certara helps its clients predict clinical outcomes, optimize dosing strategies and streamline decision-making throughout the product lifecycle.

The company’s offerings are divided into software tools and consulting services.